HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Levetiracetam may be more effective for late-onset partial epilepsy.

AbstractBACKGROUND:
Many agents are available for treating epilepsy; however, population studies have failed to show overall differences in efficacy for a given seizure type. Clinical experience suggests that certain individuals will respond to a given agent while others with the same seizure type will not.
OBJECTIVES:
To examine a population of patients who received one of the newer antiepileptic drugs, levetiracetam, and to identify those who had either a dramatic improvement or a significant worsening of seizures.
METHODS:
Retrospective medical record review of patients with refractory epilepsy.
RESULTS:
Patients who responded well to levetiracetam therapy were older at the onset of epileptic seizure than those who did not (mean [SD] age, 51 [5] vs 27 [3] years; P<.05). This was also true of the subset of patients who had localization-related epilepsy. Patients with temporal lobe onset were likely to do well whereas patients with frontal lobe onset were not.
CONCLUSIONS:
These results suggest that certain subpopulations may be particularly likely to respond to levetiracetam therapy. These need to be confirmed in a larger prospective trial; however, looking for specific characteristics of patients who respond to certain drugs may lead to useful guidelines for drug choices in treating epilepsy.
AuthorsCarl W Bazil, Andrew Rose, Stanley Resor, Bülent Yapicular, Lawrence J Hirsch
JournalArchives of neurology (Arch Neurol) Vol. 59 Issue 12 Pg. 1905-8 (Dec 2002) ISSN: 0003-9942 [Print] United States
PMID12470178 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anticonvulsants
  • Levetiracetam
  • Piracetam
Topics
  • Adult
  • Age of Onset
  • Anticonvulsants (therapeutic use)
  • Epilepsies, Partial (drug therapy, physiopathology)
  • Female
  • Humans
  • Levetiracetam
  • Male
  • Middle Aged
  • Neuropsychological Tests (statistics & numerical data)
  • Piracetam (analogs & derivatives, therapeutic use)
  • Postoperative Period
  • Preoperative Care (statistics & numerical data)
  • Retrospective Studies
  • Verbal Learning

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: